Results 131 to 140 of about 46,408 (230)

SGLT2 Inhibitors in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Tantush A, Ben Hamida B, Sagher M, Afsheen N, Sager M, Abusbaeh A, Tantoush M, Abusbaeh A, Najaim A, Alhamadi M, Hesham Gamal M, Alemam MM, Elhady MM.   +12 more
europepmc   +1 more source

Recipient Selection and Outcomes After Out‐of‐Sequence Kidney Allocation Since Implementation of Kidney Allocation System 250 (KAS250): A Single‐Center Experience

Clinical Transplantation, Volume 40, Issue 8, August 2026.
ABSTRACT Introduction Allocation out of sequence (AOOS) of kidneys has increased after KAS250 and raised concerns regarding transparency and equitable recipient selection. Less is known about recipient selection and outcomes at individual centers. Methods We performed a single‐center retrospective study of adult deceased donor kidney transplants at the
Sandesh Parajuli, Glen E. Leverson, Didier Mandelbrot, Dixon B. Kaufman   +3 more
wiley   +1 more source

Discussion on Polycystic Disease of the Kidneys [PDF]

Proceedings of the Royal Society of Medicine, 1924
openaire   +5 more sources

Progressive endocannabinoid system dysregulation in autosomal dominant polycystic kidney disease. [PDF]

Mol Med
Betkar S, Nemirovski A, Ruppo S, Hinden L, Tam J.   +4 more
europepmc   +1 more source

A proposed classification for standardized reporting of liver disease in children with autosomal recessive polycystic kidney disease

JPGN Reports, Volume 7, Issue 3, Page 477-478, August 2026.
Kavya Kurkal, Girish L. Gupte
wiley   +1 more source

Short‐Term Combined Treatment With Tirzepatide and Metformin for Overweight/Obese Chinese Women With Polycystic Ovary Syndrome: A Prospective, Open‐Label, Randomised Controlled Trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7380-7392, August 2026.
ABSTRACT Aims This study aimed to assess the effects of low‐dose tirzepatide combined with metformin (COM) versus metformin (MET) monotherapy in overweight/obese women with polycystic ovary syndrome (PCOS). Materials and Methods Sixty overweight/obese women with PCOS were randomised to the MET group (1000 mg twice daily [BID]) or the COM group (MET ...
Zhuoran Yang, Yuxin Xu, Hu Du, Wenya Liu, Haiyan Chen, Dongfang Liu, Lili Zhang, Cong Wang   +7 more
wiley   +1 more source

Perspective on Fertility Topics in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney360
Alam S, Gonzalez Suarez ML.
europepmc   +1 more source

High level of patient satisfaction with incremental haemodialysis: insights from a single‐centre patient‐reported experience study

Internal Medicine Journal, Volume 56, Issue 8, Page 1438-1442, August 2026.
Abstract A single‐centre, anonymous survey study was conducted to investigate patient experience and quality of life (Kidney Disease Quality of Life‐36) in individuals receiving incremental haemodialysis, with all 20 eligible patients participating.
Kavita L. Dilip, Louis L. Huang, Peter F. Mount   +2 more
wiley   +1 more source

Macroscopic hematuria in children with autosomal dominant polycystic kidney disease - report from four European tertiary centers. [PDF]

Eur J Pediatr
Seeman T, Bláhová K, Fencl F, John-Kroegel U, Weigel F, Šuláková T, Podracká L, Feber J.   +7 more
europepmc   +1 more source

Smooth muscle cell polycystin 1 (PKD1) is dispensable for physiological regulation of arterial contractility

The Journal of Physiology, Volume 604, Issue 15, Page 6348-6368, 1 August 2026.
Abstract figure legend Physiological functions of PKD1, a large transmembrane polycystin protein, are unclear. Previous results obtained using germline non‐specific knockout mice suggested that PKD1 regulates arterial smooth muscle cell contractility.
Angélica K. Bernardelli, Roberto B. Pontes, Alejandro Mata‐Daboin, Tessa A. C. Garrud, Ulrich C. Mbiakop, Marcos A. S. Leal, Dieniffer Peixoto‐Neves, Jonathan H. Jaggar   +7 more
wiley   +1 more source